|
Peter G. Tombros has served on the Company’s Board of Directors since November 2005 and has broad experience working with emerging and established biotechnology and pharmaceutical companies. Since 2005, Mr. Tombros has been the Professor and Executive in Residence in the Eberly College of Science BS/MBA Program at Pennsylvania State University. Prior, Mr. Tombros served as Chief Executive Officer of VivoQuest, Inc., a private biopharmaceutical company, from 2001 until its sale to XTL Biopharmaceuticals Ltd. in September 2005. For the prior seven years, Mr. Tombros was President, Chief Executive Officer and Director of Enzon, Inc. During his tenure, Enzon’s market cap grew from $44 million to $3 billion. Mr. Tombros spent the preceding 25 years serving in a variety of senior management positions at Pfizer, Inc., including Vice President of Marketing; Senior Vice President and General Manager of the Roerig Pharmaceuticals Division; Executive Vice President of Pfizer Pharmaceuticals Division; Director, Pfizer Pharmaceuticals Division; Vice President-Corporate Strategic Planning; and Vice President-Corporate Officer of Pfizer, Inc. Mr. Tombros has served as a Director of several life science companies including NPS Pharmaceuticals, Inc., Cambrex Corp. and Dendrite International, Inc. He is currently Chairman of the Board of Alpharma, Inc. Mr. Tombros received B.S. and M.S. degrees from the Pennsylvania State University and an M.B.A. from the University of Pennsylvania , Wharton Graduate School of Business. | 